簡易檢索 / 詳目顯示

研究生: 蔡淳恩
Tsai, Tsun-En
論文名稱: 禽腺病毒第四血清型疫苗之研發
Development of Vaccine Against Fowl Adenovirus serotype 4
指導教授: 柯冠銘
Ke, Guan-Ming
學位類別: 博士
Doctor
系所名稱: 獸醫學院 - 動物疫苗科技研究所
Graduate Institute of Animal Vaccine Technology
畢業學年度: 106
語文別: 中文
論文頁數: 61
中文關鍵詞: 禽腺病毒心包積液綜合症包涵體肝炎
外文關鍵詞: Fowl adenovirus, Hydropericardium Syndrome, Inclusion Body Hepatitis
DOI URL: http://doi.org/10.6346/DIS.NPUST.AVT.001.2018.D03
相關次數: 點閱:102下載:2
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統
  • 禽腺病毒第四血清型(Fowl adenovirus-4,FAdV4)是屬於禽腺病毒第I群,為無封套模的雙股DNA病毒,直徑大小約70–90 nm。FAdV4感染的臨床症狀主要為心包積液綜合症(Hydropericardium Syndrome,HPS)和包涵體肝炎(Inclusion Body Hepatitis,IBH)。HPS及IBH是一種潛伏期短,發病急,發病之後迅速波及全群的病毒,會造成雞群大量死亡和巨大的經濟損失。本研究選殖FAdV4誘發中和抗體之Hexon蛋白基因,利用大腸桿菌表現系統表現Hexon蛋白,同時利用雞肝細胞(Leghorn male hepatocellular, LMH)培養FAdV4病毒,作為疫苗抗原。結果顯示以LMH細胞培養野外分離株FAdV4/N經10代馴化其病毒量可達107.6 TCID50/mL。以大腸桿菌表現系統表現FAdV4-Hexon蛋白其表現量可達180 μg/mL。動物試驗方面,以105 TCID50 FAdV4/N病毒株與50 μg Hexon次單位蛋白混和後添加佐劑製成疫苗免疫無特定性病原雞隻,免疫後14天中和抗體可高於2048倍。在攻毒試驗結果顯示本疫苗達到完全保護的效果,免疫組雞隻全數健存,並且在攻毒14天後就偵測不到排毒。本研究發現FAdV4不活化疫苗加入次單位Hexon蛋白具有輔助免疫反應提升的效果。本研究開發以LMH細胞株用於量產FAdV4,經細胞馴化之病毒除具有具經濟價值之病毒生長力價外,並保有良好的抗原性,加入Hexon次單位蛋白可降低FAdV4病毒於疫苗中的使用量,以降低生產成本並提升疫苗之保護力。

    Fowl adenovirus serotype 4 (FAdV4) belongs to avian adenovirus group I and is a double-stranded DNA virus without envelope. The diameter is about 70-90 nm. Clinical symptoms of FAdV4 infection is mainly Hydropericardium Syndrome (HPS) and Inclusion Body Hepatitis (IBH). HPS and IBH have a short incubation period and acute onset. The virus quickly spreads through the whole organism, resulting in a large number of deaths and huge economic losses. In this study, the FAdV4 virus was cultured with chicken liver cells and was successfully passaged in LMH cells. Titer of the virus gradually increased, reaching 107.6 TCID50/mL at passage 10. The Hexon protein gene of FAdV4 was selected and expressed using the E. coli expression system, in which the protein expression reached 180 μg/mL. The inactivated 105 TCID50 FAdV4 virus along with 50 μg/mL recombination Hexon protein and adjuvant were prepared as a vaccine and used to immunize chickens. The neutralizing antibody titer, reached over 2048x dilution 14 days after immunization. When immunized chickens were challenged, complete protection was observed and no virus was detected 14 days after challenge. The present results revealed that FAdV4 virus and Hexon protein retains high antigencity and can elicit high neutralizing antibody titers. Therefore, it suggests that Hexon protein of FAdV4 could be a good candidate to be developed as a vaccine in the future.

    中文摘要 I
    Abstrate III
    謝 誌 V
    目錄 VI
    圖表目錄 IX
    第1章 緒 言 1
    第2章 文獻回顧 4
    2.1 腺病毒(Adenovirus, AdV) 4
    2.1.1腺病毒分類 4
    2.1.2腺病毒之特性 5
    2.1.3腺病毒之複製 7
    2.1.4腺病毒的應用 8
    2.2禽腺病毒第四血清型(Fowl Adenovirus type 4, FAdV4) 9
    2.2.1 FAdV4之流行病學 9
    2.2.2FAdV4之感染途徑 9
    2.2.3 FAdV4之診斷方式 10
    2.2.4 FAdV4的感染症狀 11
    2.2.5 FAdV4之預防與控制 13
    2.2.6 FAdV4病毒之分離培養及馴化 13
    2.3大腸桿菌表現系統(E. coil expression system) 14
    2.3.1大腸桿菌表現系統之載體 15
    2.4雞肝細胞(Leghorn male hepatocellular, LMH) 15
    第3章 材料與方法 16
    3.1 FAdV4培養與力價測定 16
    3.1.1 細胞培養 16
    3.1.2 FAdV4病毒之增殖 16
    3.1.3 以即時定量聚合酶連鎖反應(Real-time Quantitative Polymerase Chain Reaction, qPCR)建立病毒力價標準曲線 17
    3.1.4 病毒抗原不活化 17
    3.2 FAdV4之Hexon基因片段之選殖 18
    3.2.1FAdV4之Hexon基因特異性引子設計 18
    3.2.2聚合酶連鎖反應(Polymerase Chain Reaction, PCR) 18
    3.2.3 膠體電泳法確認PCR產物大小 18
    3.2.4 執行膠體純化回收產物 19
    3.2.5 核酸序列定序與分析 19
    3.3 建構以大腸桿菌表現FAdV4-Hexon蛋白 19
    3.3.1 載體選擇 19
    3.3.2 PCR產物限制酶切割及Ligation 19
    3.3.3 轉形 ( Transformation ) 及塗佈培養 ( Plate out ) 20
    3.3.4 重組基因之確認 ( 小量質體DNA抽取 ) 20
    3.3.5 大量質體抽取 20
    3.3.6 蛋白表現 21
    3.3.7 重組Hexon之定量與抗原性分析 21
    3.3.8 重組大腸桿菌之不活化 22
    3.4 FAdV4疫苗之製備 23
    3.5 FAdV4疫苗之安全試驗 23
    3.5.1 雞隻免疫計畫 23
    3.5.2 安全試驗-雞隻接種 24
    3.5.3雞隻保護力試驗 24
    3.6 免疫反應分析 24
    3.6.1 中和抗體試驗 24
    第4章 結 果 26
    4.1 FAdV4/N病毒株於細胞中生長情形 26
    4.2 即時定量聚合酶連鎖反應(Real-time Quantitative Polymerase Chain Reaction, qPCR)檢測FAdV4N經細胞培養後的病毒力價 26
    4.3 聚合酶連鎖反應(Polymerase Chain Reaction, PCR)選殖Hexon基因 27
    4.4 確認轉型至E. coil是否成功 27
    4.5 Hexon重組蛋白SDS-PAGE定量之結果 27
    4.6 重組Hexon蛋白之西方墨點法 (Western blotting)之結果 27
    4.7 基因定序之結果 28
    4.8 FAdV4疫苗之安全及效力評估 28
    4.8.1第一次免疫反應之試驗 28
    4.8.2 攻毒試驗 28
    4.8.3 排毒試驗 29
    4.9第二次免疫反應之試驗 29
    第5章 討 論 47
    第6章 參考文獻 51
    第7章 附 錄 56

    [1] Aldous EW, Alexander DJ. Detection and differentiation of Newcastle disease virus (avian paramyxovirus type 1). Avian pathology : journal of the WVPA. 2001;30:117-28.
    [2] Ariga T, Shimada Y, Ohgami K, Tagawa Y, Ishiko H, Aoki K, et al. New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan. Journal of clinical microbiology. 2004;42:3644-8.
    [3] Asthana M, Chandra R, Kumar R. Hydropericardium syndrome: current state and future developments. Archives of virology. 2013;158:921-31.
    [4] Balamurugan V, Kataria JM, Kataria RS, Verma KC, Nanthakumar T. Characterization of fowl adenovirus serotype-4 associated with hydropericardium syndrome in chicken. Comparative immunology, microbiology and infectious diseases. 2002;25:139-47.
    [5] Caterina KM, Frasca S, Jr., Girshick T, Khan MI. Development of a multiplex PCR for detection of avian adenovirus, avian reovirus, infectious bursal disease virus, and chicken anemia virus. Mol Cell Probes. 2004;18:293-8.
    [6] Choi KS, Kye SJ, Kim JY, Jeon WJ, Lee EK, Park KY, et al. Epidemiological investigation of outbreaks of fowl adenovirus infection in commercial chickens in Korea. Poultry science. 2012;91:2502-6.
    [7] Dar A, Gomis S, Shirley I, Mutwiri G, Brownlie R, Potter A, et al. Pathotypic and molecular characterization of a fowl adenovirus associated with inclusion body hepatitis in Saskatchewan chickens. Avian Dis. 2012;56:73-81.
    [8] Davison AJ, Benko M, Harrach B. Genetic content and evolution of adenoviruses. The Journal of general virology. 2003;84:2895-908.
    [9] Du D, Zhang P, Li X, Tian H, Cheng Y, Sheng D, et al. Cell-culture derived fowl adenovirus serotype 4 inactivated vaccine provides complete protection for virus infection on SPF chickens. Virusdisease. 2017;28:182-8.
    [10] Eckels KH, Dubois DR, Putnak R, Vaughn DW, Innis BL, Henchal EA, et al. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys. Am J Trop Med Hyg. 2003;69:12-6.
    [11] Ganesh K, Raghavan R. Hydropericardium hepatitis syndrome of broiler poultry: current status of research. Res Vet Sci. 2000;68:201-6.
    [12] Grgic H, Poljak Z, Sharif S, Nagy E. Pathogenicity and cytokine gene expression pattern of a serotype 4 fowl adenovirus isolate. PloS one. 2013;8:e77601.
    [13] Hess M. Detection and differentiation of avian adenoviruses: a review. Avian pathology : journal of the WVPA. 2000;29:195-206.
    [14] Hess M, Raue R, Prusas C. Epidemiological studies on fowl adenoviruses isolated from cases of infectious hydropericardium. Avian pathology : journal of the WVPA. 1999;28:433-9.
    [15] Hulst MM, van Gennip HG, Vlot AC, Schooten E, de Smit AJ, Moormann RJ. Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence. J Virol. 2001;75:9585-95.
    [16] Kim MS, Lim TH, Lee DH, Youn HN, Yuk SS, Kim BY, et al. An inactivated oil-emulsion fowl Adenovirus serotype 4 vaccine provides broad cross-protection against various serotypes of fowl Adenovirus. Vaccine. 2014;32:3564-8.
    [17] Li H, Wang J, Qiu L, Han Z, Liu S. Fowl adenovirus species C serotype 4 is attributed to the emergence of hepatitis-hydropericardium syndrome in chickens in China. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2016;45:230-41.
    [18] Li L, Luo L, Luo Q, Zhang T, Zhao K, Wang H, et al. Genome Sequence of a Fowl Adenovirus Serotype 4 Strain Lethal to Chickens, Isolated from China. Genome announcements. 2016;4.
    [19] Li PH, Zheng PP, Zhang TF, Wen GY, Shao HB, Luo QP. Fowl adenovirus serotype 4: Epidemiology, pathogenesis, diagnostic detection, and vaccine strategies. Poultry science. 2017;96:2630-40.
    [20] Lim TH, Lee HJ, Lee DH, Lee YN, Park JK, Youn HN, et al. Identification and virulence characterization of fowl adenoviruses in Korea. Avian Dis. 2011;55:554-60.
    [21] Liu Y, Wan W, Gao D, Li Y, Yang X, Liu H, et al. Genetic characterization of novel fowl aviadenovirus 4 isolates from outbreaks of hepatitis-hydropericardium syndrome in broiler chickens in China. Emerging microbes & infections. 2016;5:e117.
    [22] Mansoor MK, Hussain I, Arshad M, Muhammad G. Preparation and evaluation of chicken embryo-adapted fowl adenovirus serotype 4 vaccine in broiler chickens. Tropical animal health and production. 2011;43:331-8.
    [23] Mase M, Nakamura K, Imada T. Characterization of Fowl adenovirus serotype 4 isolated from chickens with hydropericardium syndrome based on analysis of the short fiber protein gene. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 2010;22:218-23.
    [24] McFerran JB, Smyth JA. Avian adenoviruses. Revue scientifique et technique. 2000;19:589-601.
    [25] Mittal D, Jindal N, Tiwari AK, Khokhar RS. Characterization of fowl adenoviruses associated with hydropericardium syndrome and inclusion body hepatitis in broiler chickens. Virusdisease. 2014;25:114-9.
    [26] Niczyporuk JS. Phylogenetic and geographic analysis of fowl adenovirus field strains isolated from poultry in Poland. Archives of virology. 2016;161:33-42.
    [27] Niu Y, Sun Q, Zhu M, Zhao J, Zhang G, Liu X, et al. Molecular epidemiology and phylogenetic analysis of fowl adenoviruses caused hydropericardium outbreak in China during 2015. Poultry science. 2018;97:803-11.
    [28] Niu YJ, Sun W, Zhang GH, Qu YJ, Wang PF, Sun HL, et al. Hydropericardium syndrome outbreak caused by fowl adenovirus serotype 4 in China in 2015. The Journal of general virology. 2016;97:2684-90.
    [29] Pei Y, Corredor JC, Griffin BD, Krell PJ, Nagy E. Fowl Adenovirus 4 (FAdV-4)-Based Infectious Clone for Vaccine Vector Development and Viral Gene Function Studies. Viruses. 2018;10.
    [30] R R, Roy P. Recombinant hexon antigen based single serum dilution ELISA for rapid serological profiling against fowl adenovirus-4 causing hydropericardium syndrome in chickens. Journal of virological methods. 2014;207:121-7.
    [31] Rahimi M, Minoosh Siavosh Haghighi Z. Adenovirus-like inclusion body hepatitis in a flock of broiler chickens in Kermanshah province, Iran. Vet Res Forum. 2015;6:95-8.
    [32] Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5:172.
    [33] Roy S, Shirley PS, McClelland A, Kaleko M. Circumvention of immunity to the adenovirus major coat protein hexon. J Virol. 1998;72:6875-9.
    [34] Schachner A, Marek A, Jaskulska B, Bilic I, Hess M. Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS). Vaccine. 2014;32:1086-92.
    [35] Schonewille E, Singh A, Gobel TW, Gerner W, Saalmuller A, Hess M. Fowl adenovirus (FAdV) serotype 4 causes depletion of B and T cells in lymphoid organs in specific pathogen-free chickens following experimental infection. Veterinary immunology and immunopathology. 2008;121:130-9.
    [36] Shah MS, Ashraf A, Khan MI, Rahman M, Habib M, Chughtai MI, et al. Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome. Archives of virology. 2017;162:1833-43.
    [37] Shah MS, Ashraf A, Khan MI, Rahman M, Habib M, Qureshi JA. Molecular cloning, expression and characterization of 100K gene of fowl adenovirus-4 for prevention and control of hydropericardium syndrome. Biologicals : journal of the International Association of Biological Standardization. 2016;44:19-23.
    [38] Shah MS, Ashraf A, Rahman M, Khan MI, Qureshi JA. A subunit vaccine against hydropericardium syndrome using adenovirus penton capsid protein. Vaccine. 2012;30:7153-6.
    [39] Sheppard M, Werner W, Tsatas E, McCoy R, Prowse S, Johnson M. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Archives of virology. 1998;143:915-30.
    [40] Steer PA, Kirkpatrick NC, O'Rourke D, Noormohammadi AH. Classification of fowl adenovirus serotypes by use of high-resolution melting-curve analysis of the hexon gene region. Journal of clinical microbiology. 2009;47:311-21.
    [41] Steglich C, Grund C, Ramp K, Breithaupt A, Hoper D, Keil G, et al. Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity. PloS one. 2013;8:e72530.
    [42] Vereecken M, de Herdt P, Ducatelle R. Adenovirus infections in pigeons: A review. Avian pathology : journal of the WVPA. 1998;27:333-8.
    [43] Xia J, Yao KC, Liu YY, You GJ, Li SY, Liu P, et al. Isolation and molecular characterization of prevalent Fowl adenovirus strains in southwestern China during 2015-2016 for the development of a control strategy. Emerging microbes & infections. 2017;6:e103.
    [44] Ye J, Liang G, Zhang J, Wang W, Song N, Wang P, et al. Outbreaks of serotype 4 fowl adenovirus with novel genotype, China. Emerging microbes & infections. 2016;5:e50.
    [45] Zhang T, Jin Q, Ding P, Wang Y, Chai Y, Li Y, et al. Molecular epidemiology of hydropericardium syndrome outbreak-associated serotype 4 fowl adenovirus isolates in central China. Virology journal. 2016;13:188.
    [46] Zhao J, Zhong Q, Zhao Y, Hu YX, Zhang GZ. Pathogenicity and Complete Genome Characterization of Fowl Adenoviruses Isolated from Chickens Associated with Inclusion Body Hepatitis and Hydropericardium Syndrome in China. PloS one. 2015;10:e0133073.

    下載圖示
    QR CODE